Status:
UNKNOWN
Descemet Membrane Endothelial Keratoplasty Combined With Intraocular Lens Exchange: Sequential Versus Combined Surgery
Lead Sponsor:
Alexandria University
Conditions:
Pseudophakic Bullous Keratopathy
Anterior Chamber Intraocular Lens
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Surgical treatment of corneal endothelial decompensation in the presence of an anterior chamber intraocular lens (AC IOL) is technically challenging. The ultimate management is to perform Descemet mem...
Detailed Description
Pseudophakic Bullous keratopathy is the second leading indication for endothelial keratoplasty. One of the main controversies in the management of PBK in the presence of an AC IOl is whether to retain...
Eligibility Criteria
Inclusion
- Patients having pseudophakic bullous keratopathy associated with an anterior chamber intraocular lens.
- Age above 18 years old.
Exclusion
- Patients with corneal stromal scarring .
- Patients who had prior glaucoma drainage devices implantation. 3 Patient with non-repairable loss in the iris tissue.
Key Trial Info
Start Date :
August 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04344522
Start Date
August 11 2020
End Date
November 1 2021
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Alexandria, Egypt, 21111